Literature DB >> 20116928

Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder.

Jeffrey R Strawn1, Gail J Pyne-Geithman, Nosakhare N Ekhator, Paul S Horn, Thomas W Uhde, Lori A Shutter, Dewleen G Baker, Thomas D Geracioti.   

Abstract

The hypothalamic neuropeptide, orexin-A has a number of regulatory effects in humans and pre-clinical evidence suggests a link to neuroendocrine systems known to be pathophysiologically related to posttraumatic stress disorder (PTSD). However, there are no reports of central nervous system (CNS) or peripheral orexin-A concentrations in patients with PTSD, or any anxiety disorder. Cerebrospinal fluid (CSF) and plasma levels of orexin-A were serially determined in patients with PTSD and healthy comparison subjects to characterize the relationships between orexin-A (in the CNS and peripheral circulation) and central indices of monoaminergic neurotransmission and to determine the degree to which CNS orexin-A concentrations reflect those in the circulating blood. CSF and plasma samples were obtained serially over a 6-h period in 10 male combat veterans with chronic PTSD and 10 healthy male subjects through an indwelling subarachnoid catheter. Orexin-A concentrations were determined in plasma and CSF and CSF levels of the serotonin metabolite, 5-hydroxyindolacetic acid (5-HIAA), and the dopamine metabolite, homovanillic acid (HVA), were determined over the sampling period. CSF and plasma orexin-A concentrations were significantly lower in the patients with PTSD as compared with healthy comparison subjects at all time points. In addition, CSF orexin-A concentrations strongly and negatively correlated with PTSD severity as measured by the Clinician-Administered PTSD Scale (CAPS) in patients with PTSD. Peripheral and CNS concentrations of orexin-A were correlated in the healthy comparison subjects and peripheral orexin-A also correlated with CNS serotonergic tone. These findings suggest low central and peripheral orexin-A activity in patients with chronic PTSD are related to symptom severity and raise the possibility that orexin-A is part of the pathophysiological mechanisms of combat-related PTSD. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20116928     DOI: 10.1016/j.psyneuen.2010.01.001

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  30 in total

Review 1.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

2.  Detection of orexin A neuropeptide in biological fluids using a zinc oxide field effect transistor.

Authors:  Joshua Hagen; Wanda Lyon; Yaroslav Chushak; Melanie Tomczak; Rajesh Naik; Morley Stone; Nancy Kelley-Loughnane
Journal:  ACS Chem Neurosci       Date:  2013-01-22       Impact factor: 4.418

3.  The Sleep/Wake Cycle is Directly Modulated by Changes in Energy Balance.

Authors:  Tinh-Hai Collet; Agatha A van der Klaauw; Elana Henning; Julia M Keogh; Diane Suddaby; Sekesai V Dachi; Síle Dunbar; Sarah Kelway; Suzanne L Dickson; I Sadaf Farooqi; Sebastian M Schmid
Journal:  Sleep       Date:  2016-09-01       Impact factor: 5.849

4.  Activation of orexin/hypocretin neurons is associated with individual differences in cued fear extinction.

Authors:  Amanda C Sharko; Jim R Fadel; Kris F Kaigler; Marlene A Wilson
Journal:  Physiol Behav       Date:  2016-10-13

5.  Associations of plasma hypocretin-1 with metabolic and reproductive health: Two systematic reviews of clinical studies.

Authors:  Galit L Dunietz; Giancarlo Vanini; Carol Shannon; Louise M O'Brien; Ronald D Chervin
Journal:  Sleep Med Rev       Date:  2020-03-17       Impact factor: 11.609

6.  Common pathways and communication between the brain and heart: connecting post-traumatic stress disorder and heart failure.

Authors:  Marlene A Wilson; Israel Liberzon; Merry L Lindsey; Yana Lokshina; Victoria B Risbrough; Renu Sah; Susan K Wood; John B Williamson; Francis G Spinale
Journal:  Stress       Date:  2019-06-04       Impact factor: 3.493

7.  Salivary protein changes in response to acute stress in medical residents performing advanced clinical simulations: a pilot proteomics study.

Authors:  Rachel K Marvin; Muncharie B Saepoo; Simiao Ye; Donald B White; Rong Liu; Kenneth Hensley; Paul Rega; Viviane Kazan; David R Giovannucci; Dragan Isailovic
Journal:  Biomarkers       Date:  2017-01-25       Impact factor: 2.658

8.  Neuroendocrine aspects of pediatric aggression: Can hormone measures be clinically useful?

Authors:  Drew H Barzman; Avni Patel; Loretta Sonnier; Jeffrey R Strawn
Journal:  Neuropsychiatr Dis Treat       Date:  2010-10-11       Impact factor: 2.570

Review 9.  The hypocretin system and psychiatric disorders.

Authors:  Fabio Pizza; Michele Magnani; Camilla Indrio; Giuseppe Plazzi
Journal:  Curr Psychiatry Rep       Date:  2014-02       Impact factor: 5.285

10.  Orexins Mediate Sex Differences in the Stress Response and in Cognitive Flexibility.

Authors:  Laura A Grafe; Amanda Cornfeld; Sandra Luz; Rita Valentino; Seema Bhatnagar
Journal:  Biol Psychiatry       Date:  2016-10-18       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.